Erlotinib and Carboplatin in Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

NCT00030446 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

50

Enrollment

NETWORK

Sponsor class

Conditions

Fallopian Tube Cancer
Ovarian Cancer
Peritoneal Cavity Cancer

Interventions

DRUG: carboplatin
DRUG: erlotinib hydrochloride

Sponsor

NCIC Clinical Trials Group